The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

Medical News

Once Daily Dosing Improves Adherence to Antiretroviral Therapy

December 5, 2011

The association of once-daily antiretroviral dosing with self-reported ART adherence was the subject of the current study. The team examined this association among participants of the Ontario Cohort Study who were currently taking ART and who had completed a 90-minute, interviewer-administered questionnaire. Missing one or more ART doses in the four days preceding the interview was defined as suboptimal adherence.

Most of the 779 participants were male (85 percent), white (67 percent), and men who have sex with men (69 percent). Their median age was 48 years (IQR 42-54); they had been taking ART for a median of nine years (IQR 5-13); and their median CD4 count was 463 cells/mm3 (IQR 320-638).

"Fifteen percent of participants reported suboptimal adherence in the four days prior to the interview," the authors wrote. A multivariable logistic regression model found that those participants taking once-daily regimens were half as likely to have missed a dose in the previous four days.

"Other independent correlates of suboptimal adherence were younger age, lower positive social interaction and increased frequency of consuming >6 alcoholic drinks on one occasion," the authors concluded.

Back to other news for December 2011

Adapted from:
AIDS and Behavior
10.2011; Vol. 15; No. 7: P. 1397-1409; Janet Raboud; and others

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
6 Reasons Why People Skip Their HIV Meds
Word on the Street: Advice on Adhering to HIV Treatment
More HIV Treatment Adherence Research

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.